Synpromics Ltd company
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Technology:
Regenerative Medicine
Investment Stage:
N/A
Estimated Revenue:
$1M to $10M
Investors Number:
3
Employee Number:
1-10
Investor Type:
Company
Number Of Exists:
Grant
Industry:
Personalized Medicine
Total Funding:
£9.2M
Founded Date:
2010
Funding Status:
N/A
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Last Funding Type:
Grant